These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6415741)

  • 1. Studies on the pharmacology of d-amphetamine on maximal electroconvulsive seizure in young chicks.
    Osuide G; Wambebe C; Ngur D
    Psychopharmacology (Berl); 1983; 81(2):119-21. PubMed ID: 6415741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dopamine, levodopa and apomorphine on maximal electroconvulsive seizure in the domestic fowl (Gallus domesticus).
    Wambebe C; Osuide G
    Jpn J Pharmacol; 1984 Aug; 35(4):339-46. PubMed ID: 6503036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of FLA-63 on pentobarbitone sleep in chicks and rats.
    Wambebe C; Osuide G
    Clin Exp Pharmacol Physiol; 1983; 10(5):555-66. PubMed ID: 6641017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J; Lewander T
    J Pharm Pharmacol; 1974 Nov; 26(11):907-9. PubMed ID: 4156566
    [No Abstract]   [Full Text] [Related]  

  • 7. Catecholaminergic involvement in the effects of amphetamine isomers on seizure susceptibility.
    Gerald MC; Gupta TK
    Eur J Pharmacol; 1977 Jan; 41(2):231-4. PubMed ID: 832677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amphetamine on brain biogenic amines in isolated and aggregated rats.
    Lokiec F; Jacquot C; Rapin JR; Cohen Y
    Eur J Pharmacol; 1977 Aug; 44(4):391-5. PubMed ID: 891613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of norepinephrine in startle arousal after acute and chronic d-amphetamine administration.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1978 Dec; 59(3):285-92. PubMed ID: 104332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats.
    Paalzow GH
    Eur J Pharmacol; 1994 Jan; 252(1):87-97. PubMed ID: 7908645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of biogenic amines in drug-induced aggressive pecking in chicks.
    Hine B; Wallach MB; Gershon S
    Psychopharmacologia; 1975 Sep; 43(3):215-21. PubMed ID: 127189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant properties of methanol leaf extract of Laggera Aurita Linn. F. (Asteraceae) in laboratory animals.
    Malami S; Kyari H; Danjuma NM; Ya'u J; Hussaini IM
    J Ethnopharmacol; 2016 Sep; 191():301-306. PubMed ID: 27321277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration.
    Bailey RC; Jackson DM
    Psychopharmacology (Berl); 1978 Apr; 56(3):317-26. PubMed ID: 418441
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of pargyline and desmethylimipramine on monoamine concentrations and amphetamine-induced glycogenolysis in the mouse brain.
    Hutchins DA
    Br J Pharmacol; 1979 Mar; 65(3):489-94. PubMed ID: 427324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain monoamines and the high pressure neurological syndrome.
    Koblin DD; Little HJ; Green AR; Daniels S; Smith EB; Paton WD
    Neuropharmacology; 1980 Nov; 19(11):1031-8. PubMed ID: 6449674
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of electroconvulsive shock on the discriminative stimulus properties of d-amphetamine and apomorphine: evidence for dopamine receptor alteration subsequent ECS.
    White DK; Barrett RJ
    Psychopharmacology (Berl); 1981; 73(3):211-4. PubMed ID: 6787638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiaton of neuropharmacological actions of apomorphine and d-amphetamine.
    Quock RM; Horita A
    Pharmacol Biochem Behav; 1976 Dec; 5(6):627-31. PubMed ID: 139615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis.
    Sabol KE; Seiden LS
    Brain Res; 1998 Sep; 806(1):69-78. PubMed ID: 9739110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia induced by amphetamine, p-chloroamphetamine and fenfluramine in the rat-1.
    Frey H-H
    Pharmacology; 1975; 13(2):163-76. PubMed ID: 124876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.